PROVIDER FILE · Evidence explainers

Mixx Health & Wellness Review: What Its GLP-1 Documents Establish—and What They Don’t

Mixx documents access to compounded injectable GLP-1/GIP treatment, but its public pages leave important questions about formulation, billing, clinical responsibility and pharmacy fulfillment unresolved.

The most important evidence question about Mixx Health & Wellness comes before any weight-loss percentage: What, exactly, would a patient receive? Its website markets compounded GLP-1/GIP injections through telemedicine, with home delivery and ongoing check-ins. Yet the consulted documentation does not identify the specific active ingredient, concentration or excipients behind that label. It also presents different starting prices and conflicting descriptions of financial commitments. Those gaps do not prove that treatment is unavailable or ineffective; they limit what a prospective patient can establish before enrolling.

This review separates three things that are easy to blur: what Mixx advertises, what its contractual documents assign to outside professionals and pharmacies, and what broader medical evidence can establish. Public documentation consulted October 19, 2026, supports describing Mixx as an access platform for compounded treatment—not as a manufacturer or a medical practice delivering every component itself. The practical task is to connect the advertised offer to a named prescription, a responsible clinical team, a dispensing pharmacy and written payment terms before treating the website as a complete account of the service.

At a glance

Documented treatment
Mixx advertises a weekly compounded GLP-1/GIP home injection kit starting at $235 per month; the homepage separately lists plans starting at $120 per month.
Sources: [5] [7]
Medical responsibility
Mixx Health and Wellness LLC says it does not practice medicine; order policies assign clinical and pharmacy-selection discretion to Elevis Medical Group.
Sources: [8] [7]
Conflicting commitment language
The FAQ advertises commitments starting at one month and no recurring charges, while the terms describe some subscriptions with three consecutive months charged at purchase.
Sources: [5] [8]
Pharmacy assignment
Promise Pharmacy is named, but policies allow Elevis Medical Group to select other pharmacy partners; a patient's preferred pharmacy is not guaranteed.
Sources: [5] [7]
Regulatory status
Mixx acknowledges that its compounded GLP-1/GIP preparation is not FDA approved or evaluated by FDA for safety, effectiveness or quality.
Sources: [6]

Start with the prescription, not the category label

Mixx’s homepage promotes compounded GLP-1/GIP injections, and its product page describes a weekly home injection kit requiring review of the patient’s medical history. The plan description includes a flat-rate physician consultation and delivery of a single compounded prescription selected by the physician. However, the consulted pages do not specify the active ingredient, concentration, excipients or supplied quantity. A category label therefore does not establish the exact preparation, and one prescription does not establish how many weeks of medication a particular purchase contains.

That distinction matters when evaluating claims about results. Evidence for a named medicine cannot automatically be attached to an unspecified compounded preparation merely because both are described with GLP-1 terminology. Our guide to formulation and route evidence explains that boundary. Mixx itself acknowledges that the compounded product is not FDA approved or evaluated by FDA for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence.

Sources: [7] [5] [6] [1]

The clinical evidence does not measure Mixx’s performance

The consulted Mixx material documents a commercial offering and service policies, not a provider-specific clinical outcomes study. It does not establish how much weight its patients lose, how often they discontinue treatment or how frequently they experience adverse effects. That is different from saying treatment cannot work. It means that claims about this platform must be supported by evidence about this platform, rather than borrowed from trials of specific medicines. The distinction is explained further in why a trial is not a telehealth performance report.

Broader clinical guidance still helps frame useful questions. NIDDK describes medication selection as a discussion of benefits, side effects, health conditions, other medicines, family history and costs, with follow-up addressing tolerance and response. Mixx’s product page makes prescribing discretionary after the initial telemedicine consultation and guarantees neither a prescription nor its duration. Its public documentation does not specify BMI criteria, required laboratory testing or the costs of any such testing. A substantive consultation should therefore explain the proposed preparation and monitoring plan, not simply confirm that payment has been accepted.

Sources: [5] [2] [3] [4]

Who is responsible for the medical service?

The terms identify Mixx Health and Wellness LLC as the website owner and operator, while expressly stating that it does not practice medicine or provide healthcare services. Its role is to facilitate access to third-party medical providers. Elsewhere, order policies give Elevis Medical Group and its clinical team discretion over prescriptions and pharmacy selection. The website also names James David Lawrence III, MD, as medical director and publishes license information. Those are provider disclosures, not independently verified credentials, and they do not fully explain the contractual relationship between Mixx and Elevis.

The entry requirements are clearer in some respects: services are limited to people at least 18 years old, or the age of majority in their jurisdiction, and informed consent is required before telemedicine. The terms also allow a professional to determine that an in-person visit or unavailable service is necessary, ending platform treatment for that issue. Prospective patients should identify the clinician or medical group responsible for their consultation and subsequent concerns. The advertised geographic reach also needs checking: the homepage claims 47 states plus Washington, DC, while the FAQ lists 40 states plus DC.

Sources: [8] [11] [7] [5]

The advertised price is not a complete purchase description

Mixx publishes actual prices, but they are not interchangeable. The homepage lists plans starting at $120 per month, without identifying the qualifying product or supply quantity. The GLP-1/GIP home injection kit starts at $235 per month, also without a specified quantity in the consulted description. Neither starting figure establishes a final charge, a renewal price or an approved prescription. The product page also displays a free-consultation promotion and code HOLIDAY10 for 10% off; eligibility, expiration and checkout application are not sufficiently documented to promise that discount on any particular order.

Included-service language needs reconciliation too. The homepage calls virtual consultations and follow-up check-ins entirely complimentary, while the product description refers to a flat-rate physician consultation included in the plan. These statements may describe different packaging, but the public material does not resolve that. Terms additionally permit applicable taxes and shipping or handling charges shown at purchase. Mixx says it does not participate in Medicare, Medicaid or other payer programs; separate clinician participation does not establish coverage here. FSA/HSA acceptance likewise is not a guarantee that an account administrator will approve the expense.

What the published prices and fees actually describe
Published amountDocumented contextBoundary to confirm
Starting at $120/monthHomepage plan advertisingQualifying product and included supply are unspecified
Starting at $235/monthCompounded GLP-1/GIP home injection kitExact formulation, quantity and final charge
Possible $125 feeApproved order cancellation or prescription changeDepends on processing and Elevis Medical Group
$100 feeCertain missed appointments, late cancellations or missing paperworkAppointment requirements still apply to advertised free consultations
Three monthly fees at purchaseCertain subscription products or servicesWhether the selected offer is a subscription
Sources: [7] [5] [8]

Enrollment language leaves the commitment unresolved

The most consequential documentary conflict concerns the obligation created by enrollment. Mixx’s FAQ advertises flexible commitments starting at one month and answers a question about subscriptions and recurring charges by saying patients pay only for prescribed products and medications. Its terms, however, contemplate some subscription products or services requiring three consecutive months, with automatic charges as described for the product. Those terms further say that the first three monthly fees are charged at purchase. This is not merely a difference between a monthly price and optional prepayment; it is unresolved language about which purchase rules apply.

For those subscriptions, the terms describe cancellation after the three-month commitment with notice 15 days before the next monthly processing date. They publish contact@elevismed.com for requests. Because this is a different domain, confirm the address and cancellation route with Mixx and retain the written instructions; no ownership relationship was independently verified. The three-month language does not establish a three-month medication supply. Before paying, request a written statement identifying the selected product, whether it renews automatically, the initial collection amount, subsequent billing dates and whether any minimum commitment applies.

Sources: [5] [8]

Pharmacy and delivery claims need a patient-specific answer

Mixx names Promise Pharmacy as the source of its compounded GLP-1/GIP preparation and lists 727-772-0500 and a Palm Harbor, Florida, address. Its terms describe Mixx as connecting patients to that pharmacy rather than operating a prescription fulfillment warehouse. But the order policy reserves selection among pharmacy partners to Elevis Medical Group. A preferred pharmacy request may be declined and does not create grounds for a refund. If a prescription is sent outside the network under the terms’ separate provision, the patient must obtain the product and pay that pharmacy directly.

Home delivery is advertised, and orders and deliveries are limited to the United States. The consulted documentation does not quantify clinical review, preparation, dispatch, transit or arrival times, or explain cold-chain standards and replacement procedures. Those omissions matter more than an unquantified promise of fast shipping; our guide to reading delivery evidence explains why. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. Separately, Mixx’s terms warn that network prescriptions are not dispensed in child-resistant packaging—an important storage detail to clarify before delivery.

Sources: [5] [7] [8] [1]

Follow-up access is documented, but response speed is not

Mixx advertises unlimited check-ins, medical support and wellness coaching, with complimentary virtual consultations and follow-ups conducted by a licensed medical professional. The terms qualify the practical meaning of access: communications may not happen in real time, and the site does not provide urgent or emergency medical services. Professionals may send clinical information through the platform, email or text, and patients are responsible for checking and responding. Unlimited check-ins therefore should not be interpreted as an immediate-response promise or as a documented schedule of clinical reassessment.

The contact page provides a form and promises a response as soon as possible, without a maximum turnaround. Published office hours are Monday through Thursday, 8 a.m.–5 p.m. EST, and Friday until 3 p.m.; weekends are by request, with evening and weekend provider appointments also advertised. Ask which channel handles side effects, refill questions and shipping problems, and who covers periods outside office hours. A clinical follow-up checklist can help separate monitoring from renewal administration. The privacy notice also allows record-copy or summary requests, usually fulfilled within 30 days, potentially with a reasonable cost-based fee.

Sources: [7] [8] [11] [9] [2]

Cancellation has several separate clocks

Mixx’s order policy says all payments are final and individualized compounded prescriptions are nonrefundable. Subscription terms contain a narrower exception when providers determine that prescribing the ordered products or services is medically inappropriate. The order policy also permits cancellation or prescription-change requests within 24 hours after payment processing, subject to Elevis Medical Group approval and a possible $125 fee depending on processing. These provisions do not establish a general 24-hour refund guarantee. Agreeing to an order or refill in communication with a provider authorizes payment processing and ordering the previously discussed prescription.

Appointments have different rules. Cancellation or rescheduling requires at least 24 hours’ notice; the policy states that otherwise a $100 missed-appointment fee will be charged to the card on file. Missing required paperwork or consent forms before the appointment also results in a stated $100 cancellation charge. Arriving five minutes or more late without prior notice and approval, or failing to answer the prompted provider call, requires rescheduling. These obligations coexist with advertising for free consultations. Keep appointment, order-change and subscription-cancellation deadlines separate, and obtain confirmation of both a requested cancellation and its financial consequences rather than assuming one resolves the other.

Sources: [8] [7] [10]

Questions & answers

Does Mixx identify the exact medicine in its GLP-1/GIP kit?

Not in the consulted public description. It identifies a weekly compounded injectable treatment but does not specify its active ingredient, concentration, excipients or supplied quantity. Request those details for the proposed prescription before comparing it with a named medicine or interpreting research results. The description of a single prescription does not establish a specific supply duration.

Sources: [5] [1]
Should I budget $120 or $235 per month?

Neither is documented as a universal final price. The homepage advertises plans starting at $120 per month; the specific home injection kit starts at $235 per month. The pages do not explain their relationship or identify the supply behind each price. Ask for an itemized offer including the exact prescription, initial payment, renewal charges and any shipping, handling or applicable taxes.

Sources: [7] [5] [8]
Can I enroll for only one month?

The FAQ advertises commitments starting at one month, but the terms describe some subscriptions requiring three consecutive months charged at purchase. The consulted documents do not establish which offer follows which rule. Obtain written confirmation for the selected plan rather than relying on the FAQ alone. A contractual commitment also does not establish how much medication will be dispensed.

Sources: [5] [8]
Will Promise Pharmacy fill my prescription?

Promise Pharmacy is named, but its involvement in every individual order is not guaranteed. Mixx’s policy allows Elevis Medical Group to choose among pharmacy partners and decline a patient’s preference without creating refund grounds. Confirm the dispensing pharmacy for the actual prescription, its contact information and who will handle delivery or product concerns before assuming the named pharmacy will be responsible.

Sources: [5] [7]
Does a free consultation mean there is no appointment-related financial risk?

No. Mixx advertises complimentary consultations, but its appointment policy states a $100 charge for certain cancellations or missed appointments and for failing to return required paperwork and consent forms before the appointment. At least 24 hours’ notice is required to cancel or reschedule. Confirm the intake deadline and appointment-management process even when the consultation itself is advertised as free.

Sources: [7] [10]
Does Mixx guarantee a prescription or a refund if treatment does not proceed?

A prescription and its duration are explicitly not guaranteed. Subscription terms describe an exception to nonrefundability when providers find the requested prescribing medically inappropriate, but the order policy broadly declares payments final. A cancellation request within 24 hours after payment remains subject to approval and a possible fee. Ask how these provisions apply to the specific purchase; they do not establish an unconditional refund promise.

Sources: [5] [8] [7]

Our assessment

Mixx documents a recognizable service pathway: telemedicine review, discretionary prescribing, pharmacy fulfillment, home delivery and advertised ongoing check-ins. It also discloses meaningful limitations, including compounded status, non-emergency communications and several cancellation charges. Those disclosures are useful, but they do not resolve the exact formulation, patient-specific pharmacy assignment, monitoring schedule or purchase obligation. The strongest reason to pause before paying is not the absence of a provider-specific weight-loss percentage; it is the mismatch between accessible marketing language and consequential contractual terms. A more decision-ready offer would identify the preparation and quantity, responsible medical group, dispensing pharmacy, total initial charge, renewal structure and applicable cancellation rules in one written record. Without that reconciliation, the public documentation supports understanding Mixx’s general access model, but not a confident conclusion about an individual purchase’s clinical suitability, complete cost or expected outcome.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. NIDDK: prescription medications for overweight and obesity ↗
  3. Wilding et al. (2021): STEP 1 semaglutide trial ↗
  4. Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
  5. Mixx Health & Wellness — glp1 gip ↗
  6. Mixx Health & Wellness — glp 1 treatment advocacy form ↗
  7. Mixx Health & Wellness — official website ↗
  8. Mixx Health & Wellness — terms of service ↗
  9. Mixx Health & Wellness — hipaa privacy policy ↗
  10. Mixx Health & Wellness — cancellation policy ↗
  11. Mixx Health & Wellness — contact us ↗

Continue reading